{"transactions":[{"id":1153871,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":79983,"kind":"person","name":"Greene Rick S.","position":1,"cik":"0001866272","reported_name":"Greene Rick S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2025-05-09T17:28:07.000Z","date":"2025-05-07","kind":"purchase","planned":false,"acquired":true,"shares":481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares are being issued as a portion of and pursuant to the Company entering into a definitive conversion agreement on May 1, 2025, with a conversion date of May 7, 2025,  along with 13 other holders of $6.6 million of the outstanding principal of the Secured Notes to convert the Secured Notes for an aggregate of 253,083 shares of the Company's Common Stock at a conversion price of $26.00 per share (on a post-reverse split basis), issuance of an aggregate of 126,540 warrants each exercisable for one share of Common Stock at an exercise price of $26.00 per share (on a post-reverse split basis), and a portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company."}],"balance_after":481,"derivative":{"exercise_price":26,"exercise_date":"2025-05-07","expiration_date":"2030-05-07","underlying":"Common Stock","underlying_shares":481},"source":{"system":"sec-edgar","filing":"0000950170-25-068271","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866272/000095017025068271/ownership.xml","form_type":"4"}},{"id":1153870,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":79983,"kind":"person","name":"Greene Rick S.","position":1,"cik":"0001866272","reported_name":"Greene Rick S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-09T17:28:07.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":962,"price":26,"value":25012.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares are being issued as a portion of and pursuant to the Company entering into a definitive conversion agreement on May 1, 2025, with a conversion date of May 7, 2025,  along with 13 other holders of $6.6 million of the outstanding principal of the Secured Notes to convert the Secured Notes for an aggregate of 253,083 shares of the Company's Common Stock at a conversion price of $26.00 per share (on a post-reverse split basis), issuance of an aggregate of 126,540 warrants each exercisable for one share of Common Stock at an exercise price of $26.00 per share (on a post-reverse split basis), and a portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company."}],"balance_after":2066,"source":{"system":"sec-edgar","filing":"0000950170-25-068271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866272/000095017025068271/ownership.xml","form_type":"4"}},{"id":1477481,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":79983,"kind":"person","name":"Greene Rick S.","position":1,"cik":"0001866272","reported_name":"Greene Rick S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-17T16:57:35.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"(1) 100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 13, 2025 or (b) the next annual meeting of stockholders, subject to the Reporting Person continuing to provide services through the vesting date."}],"balance_after":12500,"derivative":{"exercise_price":1.12,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-24-074333","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866272/000095017024074333/ownership.xml","form_type":"4"}},{"id":1625665,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":79983,"kind":"person","name":"Greene Rick S.","position":1,"cik":"0001866272","reported_name":"Greene Rick S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-22T14:23:45.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":35714,"price":1.4,"value":49999.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person purchased these shares directly from the issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended."}],"balance_after":44125,"source":{"system":"sec-edgar","filing":"0001209191-24-003786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866272/000120919124003786/doc4.xml","form_type":"4"}},{"id":1854654,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":79983,"kind":"person","name":"Greene Rick S.","position":1,"cik":"0001866272","reported_name":"Greene Rick S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T17:14:00.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 13, 2024 or (b) the next annual meeting of stockholders, subject to the Reporting Person continuing to provide services through the vesting date."}],"balance_after":12500,"derivative":{"exercise_price":2.01,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-23-037424","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866272/000120919123037424/doc4.xml","form_type":"4"}},{"id":2228279,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":79983,"kind":"person","name":"Greene Rick S.","position":1,"cik":"0001866272","reported_name":"Greene Rick S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T16:20:12.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":41841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 15, 2023 or (b) the next annual meeting of stockholders, subject to the Reporting Person continuing to provide services through the vesting date."}],"balance_after":41841,"derivative":{"exercise_price":2.39,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":41841},"source":{"system":"sec-edgar","filing":"0001209191-22-037853","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866272/000120919122037853/doc4.xml","form_type":"4"}},{"id":2242625,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":79983,"kind":"person","name":"Greene Rick S.","position":1,"cik":"0001866272","reported_name":"Greene Rick S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-06T16:16:05.000Z","date":"2022-06-02","kind":"purchase","acquired":true,"shares":4800,"price":2.0918,"value":10040.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $2.02 to $2.10. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":8411,"source":{"system":"sec-edgar","filing":"0001209191-22-034510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866272/000120919122034510/doc4.xml","form_type":"4"}},{"id":2588527,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":79983,"kind":"person","name":"Greene Rick S.","position":1,"cik":"0001866272","reported_name":"Greene Rick S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-08-27T16:42:41.000Z","date":"2021-07-22","kind":"grant","acquired":true,"shares":20964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will fully vest on July 22, 2022."}],"balance_after":20964,"derivative":{"exercise_price":4.77,"expiration_date":"2031-07-21","underlying":"Common Stock","underlying_shares":20964},"source":{"system":"sec-edgar","filing":"0001209191-21-053633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866272/000120919121053633/doc4.xml","form_type":"4"}},{"id":2588526,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":79983,"kind":"person","name":"Greene Rick S.","position":1,"cik":"0001866272","reported_name":"Greene Rick S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-27T16:42:41.000Z","date":"2021-08-25","kind":"purchase","acquired":true,"shares":3611,"price":4.1045,"value":14821.3495,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $4.09 to $4.11. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":3611,"source":{"system":"sec-edgar","filing":"0001209191-21-053633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866272/000120919121053633/doc4.xml","form_type":"4"}}]}